Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vacc-C5 in HIV-1 Infected Patients on ART
NCT01627678Phase 2Completed
- Sponsor
- Immunor
- Start
- Sep 2012
- Primary completion
- Nov 2013
- Countries
- 1
01
Overview
A Phase 2 trial of Vacc-C5 in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Immunor. Started Sep 2012; status: completed.
02
Drugs
Vacc-C5
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01627678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01627678.